rs2066459
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000534.5(PMS1):c.605G>A(p.Arg202Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0114 in 1,613,946 control chromosomes in the GnomAD database, including 169 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000534.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00791 AC: 1204AN: 152200Hom.: 11 Cov.: 31
GnomAD3 exomes AF: 0.0113 AC: 2842AN: 251238Hom.: 24 AF XY: 0.0122 AC XY: 1662AN XY: 135788
GnomAD4 exome AF: 0.0117 AC: 17167AN: 1461628Hom.: 158 Cov.: 31 AF XY: 0.0120 AC XY: 8742AN XY: 727114
GnomAD4 genome AF: 0.00788 AC: 1201AN: 152318Hom.: 11 Cov.: 31 AF XY: 0.00784 AC XY: 584AN XY: 74482
ClinVar
Submissions by phenotype
not provided Benign:2
- -
The PMS1 p.Arg202Lys variant was identified in a study by Bodian et al. (2014) which reports that this variant falls on the portion of the protein distal to the DNA-binding site and is likely to have weaker effects on protein function and hence cancer risk. The variant was identified in dbSNP (ID: rs2066459) as "With Uncertain significance allele". In ClinVar, the variant was classified as uncertain significance by three submitters: Illumina, Genomic Research Center (Shahid Beheshti University of Medical Sciences) and ITMI. The associated conditions are Lynch syndrome and hereditary breast and ovarian cancer syndrome. The variant was found in the LOVD 3.0 database, however it was not identified in Cosmic. The variant was identified in control databases in 3077 of 282642 chromosomes (26 homozygous) at a frequency of 0.010887 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: South Asian in 727 of 30610 chromosomes (freq: 0.02375), Other in 104 of 7214 chromosomes (freq: 0.01442), Ashkenazi Jewish in 148 of 10362 chromosomes (freq: 0.01428), European (non-Finnish) in 1758 of 129018 chromosomes (freq: 0.01363), Latino in 228 of 35426 chromosomes (freq: 0.006436), European (Finnish) in 63 of 25096 chromosomes (freq: 0.00251), African in 47 of 24970 chromosomes (freq: 0.001882), East Asian in 2 of 19946 chromosomes (freq: 0.0001). The variant was also identified in the following control databases: the 1000 Genomes Project, the NHLBI GO Exome Sequencing Project and the Exome Aggregation Consortium (August 8th 2016). The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, and GeneSplicer) do not predict a difference in splicing. The p.Arg202 residue is conserved in mammals but not in more distantly related organisms, however four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, and BLOSUM) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -
Hereditary breast ovarian cancer syndrome Benign:1
- -
not specified Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at